Hong Bin Dai
Fortuna: 14 M $ al 30/06/2026
Fortuna: 14 M $ al 30/06/2026
Mr. Hong Bin Dai is on the Board of Directors at Jiangsu Hengrui Pharmaceuticals Co., Ltd. He received his graduate degree from Wuhan University and a graduate degree from Zhongnan University of Economics & Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/03/2026 | 1.888.842 ( 0,03 % ) | 14 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD | Director/Miembro de la Junta | 16/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for treatment of cancer | Health Technology |
Zhongnan University of Economics & Law
Zhongnan University of Economics & Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.